Medical School

Hematology, Oncology and Transplantation

Department of Medicine

Naomi Fujioka, MD


Academic Title

Assistant Professor

Clinical Title

Medical Oncologist


  • Cancer
  • Head and Neck Cancer
  • Medical Oncology


  • Masonic Cancer Clinic


Medical School
University of Minnesota Medical School
University of Minnesota, Minneapolis, MN (Medicine)
University of Minnesota, Minneapolis, MN (Hematology/Oncology)

Administrative Contact

E: Kristin Blomquist
(612) 625-8942
F: (612) 625-6919

Office Address
Division of Hematology, Oncology and Transplantation
420 Delaware Street SE, MMC 480
Minneapolis, MN 55455

Bio Statement

Dr. Naomi Fujioka received her M.D. degree from the University of Minnesota in 2004. She completed residency training in Internal Medicine in 2007 and fellowship training in Hematology/Oncology in 2010, both at the University of Minnesota. She then spent one year as a research fellow under the mentorship of Robert Kratzke, M.D. and Stephen Hecht, Ph.D. while working on a Master of Science in Clinical Research degree through the School of Public Health. Dr. Fujioka joined the faculty in 2011.

Honors, Awards, Organizations

  • International Association for the Study of Lung Cancer
  • American Society of Clinical Oncology
  • American Association for Cancer Research

Areas of Expertise

  • Thoracic malignancies
  • Head and neck malignancies
  • Lung cancer chemoprevention

Clinical Activities

  • Co-Director, HOT Division 7D Clinical Services

Scholarly Activities

  • Thoracic Translational Working Group
Research Interests

  • Lung cancer chemoprevention

Leadership Roles
  • Co-Director, HOT Division 7D Clinical Services
  • Member, Thoracic Translational Working Group
  • Member, International Association for the Study of Lung Cancer
  • Member, American Society of Clinical Oncology
  • Member, American Association for Cancer Research


  • Fujioka N, Ainslee-Waldman CE, Upadhyaya P, Carmella SG, Fritz VA, Rohwer C, Fan Y, Rauch D, Le C, Hatsukami DK, Hecht SS. Urinary 3,3’-diindolylmethane: a biomarker of glucobrassicin exposure and indole-3-carbinol update in humans. Submitted for publication.
  • Hecht SS, Hochalter JB, Carmella SG, Zhang Y, Rauch DM, Fujioka N, Jensen N, Hatsukami DK. Longitudinal study of [D10]phenanthrene metabolism by the diol epoxide pathway in smokers. Biomarkers. 2013;18(2):144-50. PMID 23336104
  • Fujioka N, Bitterman PB. Molecular targeted therapy in lung cancer. Minn Med. 2012;95(10):38-41.
    PMID 23193704.
  • Fujioka N, Nguyen J, Chen C, Li Y, Pasrija T, Niehans G, Johnson KN, Gupta V, Kratzke RA, Gupta K. Morphine induced epidermal growth factor pathway activation in non-small-cell lung cancer. Anesth Analg. 2011; 113(6):1353-64. PMID 22003224.
  • Fujioka N, French CA, Cameron MJ, Kratzke RA. Long term survival of a patient with non-small-cell lung cancer harboring NUT gene rearrangement. J Thorac Oncol. 2010;5:1704-05. PMID 20871268.
  • Fujioka N, Dudek A, Kirstein MN, Kumar P. Phase I study of sorafenib, cisplatin, and pemetrexed for the treatment of advanced solid tumors (abstract). J Clin Oncol. 2010 (suppl; abstr e13055).
  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on March 3, 2015